Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes.

Jiang YD, Chang YC, Chiu YF, Chang TJ, Li HY, Lin WH, Yuan HY, Chen YT, Chuang LM.

BMC Med Genet. 2010 Aug 25;11:126. doi: 10.1186/1471-2350-11-126.

2.

Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.

Lin WH, Chuang LM, Chen CH, Yeh JI, Hsieh PS, Cheng CH, Chen YT.

Diabetologia. 2006 Jun;49(6):1214-21. Epub 2006 Apr 4.

PMID:
16586067
3.

Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes.

Pollex RL, Mamakeesick M, Zinman B, Harris SB, Hanley AJ, Hegele RA.

Cardiovasc Diabetol. 2005 Nov 7;4:17.

4.

Association of the -250G/A promoter polymorphism of the hepatic lipase gene with the risk of peripheral arterial disease in type 2 diabetic patients.

Valdivielso P, Ariza MJ, de la Vega-Román C, González-Alegre T, Rioja J, Ulzurrun E, González-Santos P.

J Diabetes Complications. 2008 Jul-Aug;22(4):273-7. doi: 10.1016/j.jdiacomp.2007.06.011. Epub 2008 Apr 16.

PMID:
18413186
5.

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.

Libra M, Signorelli SS, Bevelacqua Y, Navolanic PM, Bevelacqua V, Polesel J, Talamini R, Stivala F, Mazzarino MC, Malaponte G.

J Clin Pathol. 2006 Feb;59(2):211-5.

6.

Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: role of ACE D/-240T haplotype.

Fatini C, Sticchi E, Sofi F, Said AA, Pratesi G, Pulli R, Pratesi C, Abbate R.

J Vasc Surg. 2009 Dec;50(6):1399-404. doi: 10.1016/j.jvs.2009.07.075. Epub 2009 Sep 26.

7.

Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes.

Bento JL, Bowden DW, Mychaleckyj JC, Hirakawa S, Rich SS, Freedman BI, Segade F.

BMC Med Genet. 2005 Dec 7;6:42.

8.
9.

Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits.

Andersen G, Rose CS, Hamid YH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O.

Diabetes. 2003 Sep;52(9):2445-8.

10.

eNOS and ACE genes influence peripheral arterial disease predisposition in smokers.

Sticchi E, Sofi F, Romagnuolo I, Pratesi G, Pulli R, Pratesi C, Abbate R, Fatini C.

J Vasc Surg. 2010 Jul;52(1):97-102.e1. doi: 10.1016/j.jvs.2010.02.021. Epub 2010 May 15.

11.

Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.

Beránek M, Kanková K, Benes P, Izakovicová-Hollá L, Znojil V, Hájek D, Vlková E, Vácha J.

Am J Med Genet. 2002 May 15;109(4):278-83.

PMID:
11992481
12.
13.

The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus.

Lacquemant C, Froguel P, Lobbens S, Izzo P, Dina C, Ruiz J.

Diabet Med. 2004 Jul;21(7):776-81.

PMID:
15209773
15.

Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.

Hsieh MC, Tien KJ, Perng DS, Hsiao JY, Chang SJ, Liang HT, Chen HC, Tu ST.

Metabolism. 2009 Apr;58(4):504-9. doi: 10.1016/j.metabol.2008.11.008.

PMID:
19303971
16.

Characterization and expression pattern analysis of the facilitative glucose transporter 10 gene (slc2a10) in Danio rerio.

Chiarelli N, Ritelli M, Zoppi N, Benini A, Borsani G, Barlati S, Colombi M.

Int J Dev Biol. 2011;55(2):229-36. doi: 10.1387/ijdb.103179nc.

17.

Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patients.

Bleda S, De Haro J, Varela C, Esparza L, De Maturana IL, Acin F.

Growth Factors. 2012 Oct;30(5):277-82. Epub 2012 Jul 5.

PMID:
22762535
18.

The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study.

Reny JL, Alhenc-Gelas M, Fontana P, Bissery A, Julia PL, Fiessinger JN, Aiach M, Emmerich J.

J Thromb Haemost. 2004 Aug;2(8):1334-40.

19.

Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families.

Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B, Ramos-Arroyo MA, Doco-Fenzy M, Hennekam RC, Pyeritz RE, Krogmann ON, Gillessen-kaesbach G, Wakeling EL, Nik-zainal S, Francannet C, Mauran P, Booth C, Barrow M, Dekens R, Loeys BL, Coucke PJ, De Paepe AM.

Hum Mutat. 2008 Jan;29(1):150-8.

PMID:
17935213
20.

A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes.

Ciccarone E, Di Castelnuovo A, Salcuni M, Siani A, Giacco A, Donati MB, De Gaetano G, Capani F, Iacoviello L; Gendiabe Investigators.

J Thromb Haemost. 2003 Aug;1(8):1744-52.

Supplemental Content

Support Center